PD-L1 inhibition recovered only the expression of CD69 (figure 5F, G group E (PC3 tumor+T cells+IFN-γ+anti-PD-1)), which is the primary activation marker of T cells and can prevent the harmful effects of tryptamine deletion caused by IDO-1. Here, CD69 is linked to neoplasm.